A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation

• Status: Completed
• Trial end date: 2011-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to re-evaluate the therapeutic superiority and safety of acupuncture treatment using high quality and large sampled clinical research. The investigators want to provide a preferred treatment protocol, which is effective, safe, and easy to use in clinical practice. This research also clarifies that the insertion depth is a key factor in the therapeutic effect of acupuncture. The results of the study will help promote the development of the standardization of acupuncture.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Collaborator: Ministry of Science and Technology of the People´s Republic of China
• Treatments: Lactulose

Criteria

Inclusion Criteria:

• meeting the diagnosis of Rome III criteria;

• aged from 18 to 75 years old;

• no use of medicine for constipation about 2 weeks before the enrollment, no acupuncture treatment for constipation in the previous 3 months, and never joined any other trial in progress in the previous 3 months;

• volunteered to join this trial and signed the informed consent form

Exclusion Criteria:

• irritable bowel syndrome, organic constipation or secondary constipation caused by endocrine, metabolic, nervous, postoperative diseases, or by drugs;

• constipation with serious cardiovascular, hepatic or renal diseases, cognitive dysfunction, aphasia, mental disorders, or illness which affects the cooperation for examination and treatment;

• women in gestation or lactation period;

• abdominal aortic aneurysm or hepatosplenomegaly, etc.;

• blood coagulation disorders or using anticoagulants regularly such as Warfarin and Heparin;

• cardiac pacemaker carrier.